262 related articles for article (PubMed ID: 27119533)
1. Alterations in inflammatory biomarkers and energy intake in cancer cachexia: a prospective study in patients with inoperable pancreatic cancer.
Bye A; Wesseltoft-Rao N; Iversen PO; Skjegstad G; Holven KB; Ulven S; Hjermstad MJ
Med Oncol; 2016 Jun; 33(6):54. PubMed ID: 27119533
[TBL] [Abstract][Full Text] [Related]
2. A predictive model of inflammatory markers and patient-reported symptoms for cachexia in newly diagnosed pancreatic cancer patients.
Fogelman DR; Morris J; Xiao L; Hassan M; Vadhan S; Overman M; Javle S; Shroff R; Varadhachary G; Wolff R; Vence L; Maitra A; Cleeland C; Wang XS
Support Care Cancer; 2017 Jun; 25(6):1809-1817. PubMed ID: 28111717
[TBL] [Abstract][Full Text] [Related]
3. Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia.
Martignoni ME; Kunze P; Hildebrandt W; Künzli B; Berberat P; Giese T; Klöters O; Hammer J; Büchler MW; Giese NA; Friess H
Clin Cancer Res; 2005 Aug; 11(16):5802-8. PubMed ID: 16115919
[TBL] [Abstract][Full Text] [Related]
4. Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia.
Penafuerte CA; Gagnon B; Sirois J; Murphy J; MacDonald N; Tremblay ML
Br J Cancer; 2016 Mar; 114(6):680-7. PubMed ID: 26954714
[TBL] [Abstract][Full Text] [Related]
5. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.
La Torre M; Nigri G; Cavallini M; Mercantini P; Ziparo V; Ramacciato G
Ann Surg Oncol; 2012 Sep; 19(9):2917-23. PubMed ID: 22488099
[TBL] [Abstract][Full Text] [Related]
6. Systemic inflammation correlates with increased expression of skeletal muscle ubiquitin but not uncoupling proteins in cancer cachexia.
DeJong CH; Busquets S; Moses AG; Schrauwen P; Ross JA; Argiles JM; Fearon KC
Oncol Rep; 2005 Jul; 14(1):257-63. PubMed ID: 15944798
[TBL] [Abstract][Full Text] [Related]
7. Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients.
Batista ML; Olivan M; Alcantara PS; Sandoval R; Peres SB; Neves RX; Silverio R; Maximiano LF; Otoch JP; Seelaender M
Cytokine; 2013 Feb; 61(2):532-9. PubMed ID: 23200412
[TBL] [Abstract][Full Text] [Related]
8. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.
Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329
[TBL] [Abstract][Full Text] [Related]
9. Tumour-derived transforming growth factor-β signalling contributes to fibrosis in patients with cancer cachexia.
Lima JDCC; Simoes E; de Castro G; Morais MRPT; de Matos-Neto EM; Alves MJ; Pinto NI; Figueredo RG; Zorn TMT; Felipe-Silva AS; Tokeshi F; Otoch JP; Alcantara P; Cabral FJ; Ferro ES; Laviano A; Seelaender M
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1045-1059. PubMed ID: 31273954
[TBL] [Abstract][Full Text] [Related]
10. Cancer cachexia, sarcopenia and biochemical markers in patients with advanced non-small cell lung cancer-chemotherapy toxicity and prognostic value.
Srdic D; Plestina S; Sverko-Peternac A; Nikolac N; Simundic AM; Samarzija M
Support Care Cancer; 2016 Nov; 24(11):4495-502. PubMed ID: 27236439
[TBL] [Abstract][Full Text] [Related]
11. Bacterial translocation contributes to cachexia from locally advanced gastric cancer.
Mi L; Lin J; Zheng H; Xu X; Zhang J; Zhang D
Hepatogastroenterology; 2012 Oct; 59(119):2348-51. PubMed ID: 22709824
[TBL] [Abstract][Full Text] [Related]
12. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
[TBL] [Abstract][Full Text] [Related]
13. Serum adipokine zinc α2-glycoprotein and lipolysis in cachectic and noncachectic heart failure patients: relationship with neurohormonal and inflammatory biomarkers.
Tedeschi S; Pilotti E; Parenti E; Vicini V; Coghi P; Montanari A; Regolisti G; Fiaccadori E; Cabassi A
Metabolism; 2012 Jan; 61(1):37-42. PubMed ID: 21696792
[TBL] [Abstract][Full Text] [Related]
14. Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer.
Ramsey ML; Talbert E; Ahn D; Bekaii-Saab T; Badi N; Bloomston PM; Conwell DL; Cruz-Monserrate Z; Dillhoff M; Farren MR; Hinton A; Krishna SG; Lesinski GB; Mace T; Manilchuk A; Noonan A; Pawlik TM; Rajasekera PV; Schmidt C; Guttridge D; Hart PA
Pancreatology; 2019 Jan; 19(1):80-87. PubMed ID: 30497874
[TBL] [Abstract][Full Text] [Related]
15. Elevation in multiple serum inflammatory biomarkers predicts survival of pancreatic cancer patients with inoperable disease.
Alkhateeb A; Zubritsky L; Kinsman B; Leitzel K; Campbell-Baird C; Ali SM; Connor J; Lipton A
J Gastrointest Cancer; 2014 Jun; 45(2):161-7. PubMed ID: 24446242
[TBL] [Abstract][Full Text] [Related]
16. Detection of Pancreatic Cancer-Induced Cachexia Using a Fluorescent Myoblast Reporter System and Analysis of Metabolite Abundance.
Winnard PT; Bharti SK; Penet MF; Marik R; Mironchik Y; Wildes F; Maitra A; Bhujwalla ZM
Cancer Res; 2016 Mar; 76(6):1441-50. PubMed ID: 26719527
[TBL] [Abstract][Full Text] [Related]
17. Lipocalin-2 and neutrophil activation in pancreatic cancer cachexia.
Deng M; Aberle MR; van Bijnen AAJHM; van der Kroft G; Lenaerts K; Neumann UP; Wiltberger G; Schaap FG; Olde Damink SWM; Rensen SS
Front Immunol; 2023; 14():1159411. PubMed ID: 37006254
[TBL] [Abstract][Full Text] [Related]
18. Cancer cachexia induces morphological and inflammatory changes in the intestinal mucosa.
Costa RGF; Caro PL; de Matos-Neto EM; Lima JDCC; Radloff K; Alves MJ; Camargo RG; Pessoa AFM; Simoes E; Gama P; Cara DC; da Silva ASF; O Pereira W; Maximiano LF; de Alcântara PSM; Otoch JP; Trinchieri G; Laviano A; Muscaritoli M; Seelaender M
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):1116-1127. PubMed ID: 31307125
[TBL] [Abstract][Full Text] [Related]
19. Comparing two classifications of cancer cachexia and their association with survival in patients with unresected pancreatic cancer.
Wesseltoft-Rao N; Hjermstad MJ; Ikdahl T; Dajani O; Ulven SM; Iversen PO; Bye A
Nutr Cancer; 2015; 67(3):472-80. PubMed ID: 25710201
[TBL] [Abstract][Full Text] [Related]
20. Diabetes increases mortality in patients with pancreatic and colorectal cancer by promoting cachexia and its associated inflammatory status.
Chovsepian A; Prokopchuk O; Petrova G; Gjini T; Kuzi H; Heisz S; Janssen KP; Martignoni ME; Friess H; Hauner H; Rohm M
Mol Metab; 2023 Jul; 73():101729. PubMed ID: 37094629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
